Precision oncology relies on exact quantification of rare genetic mutations within heterogeneous biological samples. Quantitative nucleic acid measurement guides targeted therapy selection and tracks therapeutic response during clinical trials. Partition-based amplification technologies enable absolute target quantification without requiring external standard curves. This high analytical sensitivity helps researchers detect low-abundance target…